Kyowa Kirin - Public Comps and Valuation Multiples

Kyowa Kirin Overview

About Kyowa Kirin

Kyowa Kirin, formerly Kyowa Hakko Kirin, was formed in 2008 through the merger of Kyowa Hakko Kogyo and Kirin Pharma following the capital alliance between Kyowa Hakko Group and Kirin Group. Kyowa Kirin is a Japan-based pharmaceutical company with strong expertise in antibody technology. Its core drugs are the rare disease treatments Crysvita and Poteligeo. As of 2024, North America is its largest revenue contributor, with around 35% of total sales largely driven by Crysvita. Japan is the second-largest, making up 27%.

Founded

1949

HQ

Employees

5.7K+

Website

kyowakirin.co.jp

Sectors

Biopharmaceuticals
Drug Development & Therapeutics
BioTech

Financials

LTM Revenue $3.2B

LTM EBITDA $718M

EV

$6.2B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Kyowa Kirin Financials

As of September 2025, Kyowa Kirin reported last 12-month revenue of $3.2B and EBITDA of $718M.

In the same period, Kyowa Kirin generated $2.4B in LTM gross profit and $376M in net income.

See Kyowa Kirin valuation multiples based on analyst estimates

Kyowa Kirin P&L

In the most recent fiscal year, Kyowa Kirin reported revenue of $3.3B and EBITDA of $759M.

Kyowa Kirin expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Kyowa Kirin valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$3.2B	XXX	$3.3B	XXX	XXX	XXX
Gross Profit	$2.4B	XXX	$2.4B	XXX	XXX	XXX
Gross Margin	74%	XXX	73%	XXX	XXX	XXX
EBITDA	$718M	XXX	$759M	XXX	XXX	XXX
EBITDA Margin	23%	XXX	23%	XXX	XXX	XXX
EBIT	$545M	XXX	$603M	XXX	XXX	XXX
EBIT Margin	17%	XXX	19%	XXX	XXX	XXX
Net Profit	$376M	XXX	$393M	XXX	XXX	XXX
Net Margin	12%	XXX	12%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Kyowa Kirin including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $3.2B. EBITDA for the last twelve months was $718M. In the most recent fiscal year, Kyowa Kirin achieved $3.3B in revenue and $759M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$3.2B	Analyst estimates available to subscribers	$3.3B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$2.4B	Analyst estimates available to subscribers	$2.4B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	74.4% gross margin	Analyst estimates available to subscribers	73.2% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$718M	Analyst estimates available to subscribers	$759M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	22.7% EBITDA margin	Analyst estimates available to subscribers	23.4% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$545M	Analyst estimates available to subscribers	$603M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	17.2% EBIT margin	Analyst estimates available to subscribers	18.5% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$376M	Analyst estimates available to subscribers	$393M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	11.9% net profit margin	Analyst estimates available to subscribers	12.1% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Kyowa Kirin

This financial data table provides comprehensive performance metrics for Kyowa Kirin, a company based in Japan. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Kyowa Kirin generated $3.2B in revenue over the last twelve months.
The company achieved $718M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $2.4B.
Net income over the last twelve months reached $376M.

Fiscal Year Performance

In the most recent fiscal year, Kyowa Kirin reported $3.3B in total revenue.
Fiscal year EBITDA was $759M.
The company maintained a gross profit margin of 73.2% in the most recent fiscal year.
EBITDA margin for the fiscal year was 23.4%.
Net profit margin reached 12.1% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Kyowa Kirin. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Kyowa Kirin Stock Performance

Kyowa Kirin has current market cap of JPY 1.19T (or $7.8B), and EV of JPY 953B (or $6.2B).

Market Cap Evolution

Kyowa Kirin Stock Data

As of October 17, 2025, Kyowa Kirin's stock price is JPY 2271 (or $15).

See Kyowa Kirin trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$6.2B	$7.8B	XXX	XXX	XXX	XXX	$0.71

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Kyowa Kirin Valuation Multiples

Kyowa Kirin's trades at 1.9x EV/Revenue multiple, and 8.2x EV/EBITDA.

See valuation multiples for Kyowa Kirin and 15K+ public comps

Kyowa Kirin Financial Valuation Multiples

As of October 17, 2025, Kyowa Kirin has market cap of $7.8B and EV of $6.2B.

Equity research analysts estimate Kyowa Kirin's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Kyowa Kirin has a P/E ratio of 20.7x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$7.8B	XXX	$7.8B	XXX	XXX	XXX
EV (current)	$6.2B	XXX	$6.2B	XXX	XXX	XXX
EV/Revenue	2.0x	XXX	1.9x	XXX	XXX	XXX
EV/EBITDA	8.7x	XXX	8.2x	XXX	XXX	XXX
EV/EBIT	11.5x	XXX	10.4x	XXX	XXX	XXX
EV/Gross Profit	2.7x	XXX	n/a	XXX	XXX	XXX
P/E	20.7x	XXX	19.9x	XXX	XXX	XXX
EV/FCF	-48.9x	XXX	-25.5x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Kyowa Kirin Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Kyowa Kirin Margins & Growth Rates

Kyowa Kirin's last 12 month revenue growth is 3%

Kyowa Kirin's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.3M for the same period.

Kyowa Kirin's rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Kyowa Kirin's rule of X is 30% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Kyowa Kirin and other 15K+ public comps

Kyowa Kirin Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	3%	XXX	1%	XXX	XXX	XXX
EBITDA Margin	23%	XXX	23%	XXX	XXX	XXX
EBITDA Growth	7%	XXX	-5%	XXX	XXX	XXX
Rule of 40	30%	XXX	26%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	30%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.6M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.3M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	21%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	55%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial